All In Biotech

Drug Trial Radar · NCT03357822

A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B

A Real-World Study of Sequential Combination Therapy With Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B

Last checked: Nov 20, 2026Latest source record: Apr 25, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

2,000

Planned (sponsor's estimate)

Start

Jan 25, 2018

Primary completion

Jan 25, 2022

Study completion Jul 25, 2022

Sponsor

Lead sponsor
Tongji HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 30, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of the prospective real-world study is to evaluate whether sequential combination therapy with pegylated interferon plus entecavir/tenofovir could induce higher rates of HBsAg loss in nucleoside-treated patients with chronic hepatitis B compared to continuous nucleoside treatment.

Conditions

  • Chronic Hepatitis B

Interventions

  • Pegylated interferonDrug

    180ug Pegylated interferon is injected subcutaneously once a week

  • EntecavirDrug

    0.5mg entecavir is orally taken every day

  • Tenofovir disoproxil fumarateDrug

    300mg tenofovir is orally taken every day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. HBsAg loss rateTime frame: at week 48

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • 302 Military Hospital of China

    Beijing, Beijing Municipality, China · Recruiting

  • BeiJing YouAn Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Not yet recruiting

  • The First Hospital Affiliated to AMU

    Chongqing, Chongqing Municipality, China · Not yet recruiting

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, China · Not yet recruiting

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Not yet recruiting

  • The First Affiliated Hospital of College of Medicine, Zhejiang University

    Zhejiang, Hangzhou, China · Not yet recruiting

  • Departmen of infectious disease, Xiangya Hospital, Central-south Universit

    Changsha, Hunan, China · Not yet recruiting

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, China · Not yet recruiting

  • The First Affiliated Hospital with Nanjing Medical University

    Nanjing, Jiangsu, China · Not yet recruiting

  • The Second Hospital of Nanjing

    Nanjing, Jiangsu, China · Not yet recruiting

  • Traditional Chinese Medicine,Xiamen Hospital

    Shantou, Xiamen, China · Not yet recruiting

  • The first affiliated hospital of Wenzhou medical universtiy

    Wenzhou, Zhejiang, China · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.